Trials / Recruiting
RecruitingNCT04425434
Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- French Africa Pediatric Oncology Group · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
As the survival of children with retinoblastoma in high income countries is higher than 95% including the bilateral forms this study hopes to improve the outcome in low income countries in Africa by improving early diagnosis and early implementation of this protocol of therapeutic recommendations for treatment.
Detailed description
In this study we will try to improve the outcome for children with stage II disease. It is hoped that we will be able to show that with early intervention correct early diagnosis the survival of these children is greatly improved. The collection of data in this observational study will allow us to show this improvement, by analysis of stage, treatment and outcome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | OBSERVATIONAL | We will look at the outcome of the the children treated to see if the survival is improved when these therapeutic measures are followed. |
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2028-12-31
- Completion
- 2030-12-31
- First posted
- 2020-06-11
- Last updated
- 2026-03-02
Locations
7 sites across 6 countries: Burkina Faso, Côte d’Ivoire, Democratic Republic of the Congo, Madagascar, Mali, Senegal
Source: ClinicalTrials.gov record NCT04425434. Inclusion in this directory is not an endorsement.